Ilona Z.
- Country
- Poland
- Department
- Klinika Chorób Nerek i Nadciśnienia Dzieci i Młodzieży
Research Overview
- Efficacy and Safety of Prolonged-Release Budesonide Versus Prednisone in Pediatric Primary IgA Nephropathy: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of Pharmacokinetics, Safety, and Efficacy of Empagliflozin in Pediatric Patients with Chronic Kidney Disease: A Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 3 of 44 partner sites.
Specializations
Pediatric Nephrology
This investigator specializes in studying pediatric kidney disorders, with particular emphasis on IgA nephropathy in children. Their research encompasses innovative therapeutic approaches for managing primary kidney conditions in young patients.
- Primary IgA Nephropathy
- Pediatric Proteinuria Management
- Kidney Disease in Children
Their work focuses on evaluating treatment efficacy in reducing proteinuria among pediatric populations with kidney disorders.
Therapeutic Applications
The investigator explores novel therapeutic applications in pediatric nephrology, particularly examining the effectiveness of prolonged-release medications in treating kidney conditions. Their research includes comparative studies of different treatment modalities.
- Extended-Release Formulations
- Combination Therapy Approaches
- Treatment Optimization
Their investigations center on developing more effective treatment strategies for pediatric kidney disorders.
Clinical Outcomes
The investigator's research evaluates clinical efficacy and safety profiles of treatments for pediatric kidney diseases. Their work encompasses comprehensive assessment of therapeutic interventions in young patients with nephropathy.
- Treatment Safety Assessment
- Efficacy Evaluation
- Pediatric Patient Outcomes
Their studies focus on measuring treatment responses in children with primary kidney conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
